Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockman6767on Oct 28, 2016 3:09pm
129 Views
Post# 25399810

RE:RE:Telesta deal

RE:RE:Telesta dealIt is not clear to me if that will be the volume-weighted average of ALL trades during the entire 5 days, or will it be the volume-weighted average of the just the closing prices for those 5 days?

If it is the former then they could do a high volume of cross selling once they have achieved a low price at some time during the day and let the price rise again after their low price high volume cross-sales - take for example todays high volume crosses.

whatever, I now hope the seli-off is now almost over. Looking forward to the remaining NRs before Nov 21 and the analyst meeting itself and the new insights it will unfold for the future of PLI.

Glta
Stockman6767
Bullboard Posts